Bioprocess Technology Market

Bioprocess Technology Market Outlook

Bioprocess technology market valuation is anticipated to expand at a CAGR 14.8% over the forecast period of 2021 to 2031, as per the latest study by Fact.MR, a market research and competitive intelligence provider. Demand for bioprocess engineering in biotechnology is set to be valued at around US$ 78.8 Bn by 2031-end, which amounts to around 4% share of the overall biotechnology market.

Globally, the bioprocess technology market experienced a downfall in its demand curve in 2020 due to the COVID-19 pandemic. However, owing to rising demand for next-generation bio-based products, followed by increasing production of bio-based products of late, the market has bounced back since the beginning of 2021. Fact.MR. has analysed that bioprocess technology in biopharmaceutical applications holds a significant market share, a trend that is likely to continue in the near future as well.

Bioprocess Technology Market Size 2020	US$ 16.5 Bn
Market Forecast Value for 2031	US$ 78.8 Bn
Global Growth Rate (2021 to 2031)	14.8% CAGR
North America Market Size in 2020	US$ 5.4 Bn

Demand Analysis of Bioprocess Technology from 2016 to 2020 Vs Market Outlook for 2021 to 2031

The global bioprocess technology market has witnessed a strong growth rate of 11.6% over the historical period with sales pegged at US$ 16.5 Bn in 2020. Growing focus on preventing measures along with alternative medicines for specific uses are driving the sales figures of bioprocess technology. New production sites and expansion of existing sites in emerging markets are key factors influencing overall market growth.

The global bioprocess technology space has evolved remarkably in the past half-decade on the back of increasing investments in new technologies to overcome performance and quality issues associated with the manufacturing of bioprocess products.

Shifting preference towards bio-based products derived from biodegradable and fossil fuels is creating growth avenues in potential markets. Based on the aforementioned trends, global bioprocess technology demand is expected to surge at a CAGR of 14.8% over the period (2021-2031).

• Application of bioprocess technology in biopharmaceuticals holds the highest market share and is anticipated to rise at a CAGR 13.4% over the forecast period.
• North America accounted for a major share of the market. The regional market expanded at a CAGR 11.7% during 2016-2020 and held approx. 33% global market share in 2020.
• Demand for bioprocess technology in hospitals and research labs is anticipated to increase at a significant pace over the forecast period.
• Cell culture bioprocess technology is the most significant type adopted by consumers across the globe.

What are the Prominent Driving Factors for the Bioprocess Technology Business?

Primary reason behind the swift progress of bioprocess technology can be accounted to the evolution of biopharmaceutical and biotechnology industries.

Increasing prevalence of chronic diseases is also one of the main factors driving demand for bioprocess technology. Upsurge in demand for new drugs initiates the need for bioprocess technology. Additionally, personalized treatment for diseases such as cancer is intensifying demand for various bioprocess therapies, including cell therapy.

In recent years, the importance of research & development in the life sciences industry has been strongly promoted. Due to this trend, government support for pharmaceutical and biotech industries is also increasing.

Another rapidly growing bioprocess technology field is oligosaccharide manufacturing. Due to the uncountable health benefits in treating chronic diseases, they have numerous promising applications in the F&B industry. These effects have led to a surge in market demand for bioprocess technology.

Country-wise Analysis

Why is the U.S. a Prominent Market for Bioprocess Technology?

Over the period of 2016-2020, bioprocess technology demand in the United States surged at a CAGR 12.1% and reached over US$ 5.4 Bn in 2020, which is anticipated to top US$ 26 Bn by 2031-end.

The U.S. is estimated to account for around 88.7% value share in North America. Increasing requirements for upstream bioprocess technology equipment in the country is the primary reason for its dominance. Escalating living standards, increasing disposable income, along with growing health consciousness are also the reasons behind rapid growth of the bioprocess technology market in the U.S.

Will Bioprocess Technology in Germany Evolve at a Rapid Pace?

The market for bioprocess technology in Germany is anticipated to rise at a CAGR 11.2% over the forecast period.

The country held over 27% of overall European demand in 2020. Rising inclination towards bio-based medicines is the prime factor behind high demand for bioprocess technology in Germany. Other factors such as reduced and reuse of wastage also fuelling the requirement for bioprocess technology in the country.

Why India is the Highest Contributor to Bioprocess Technology in South Asia & Oceania?

The bioprocess technology market in India is anticipated to rise rapidly at a CAGR 19% through 2031. The country held over 52% of the South Asia & Oceania market share in 2020.

Growing production of biopharmaceuticals such as vaccines and recombinant proteins are the primary reasons behind rapid market growth. The country is also one of the leading manufacturers of vaccines, which inevitably makes it a key market for bioprocess technology.

Category-wise Analysis

Which is the Most Preferred Bioprocess Technology Type?

Bioprocess technology has become one of the most significant sectors in the healthcare industry with the advent of new technologies in recent years. Cell culture bioprocessing is the most prominent bioprocessing technology type, and the segment is anticipated to surge at a CAGR 18.7% over the decade.

Rising investments in research and technology are also proliferating demand for cell culture bioprocess technology. Cell culture is used as a model system to studying basic cell biology and biochemistry. Biological studies on the effect of drugs, process of aging, and interaction between cells and disease-causing agent like bacteria and virus are significantly fuelling bioprocess technology demand.

Why is the Biopharmaceutical Sector the Most Prominent Revenue Generator for Bioprocess Technology?

The biopharmaceuticals sector across the globe has continued its positive momentum over the past half-decade. The global biopharmaceutical industry was valued at around US$ 320 Bn in 2020, and is anticipated to top US$ 490 Bn by 2031. Innovative drugs for sustained patient outcomes will continue to play a key role in the growth of the bio-pharmaceuticals sector. Looking into the demand trend, manufacturers of biopharmaceuticals are focusing on increasing their production to cater high market requirements.

Competitive landscape

Key players are focusing on market expansion by following both, inorganic and organic approaches.

• In 2017, GE Healthcare acquired Puridify, a bioprocessing start-up that develops nanofiber-based platform purification technology for the production of biopharmaceutical. Puridify's FibroSelect technology complements the bead resins and chromatography membranes that are utilized in downstream bioprocessing processes today, achieving faster mass transfer & scalability, and ease of use.

Report Scope

Report Attributes	Details
Forecast Period	2021-2031
Historical Data Available for	2016-2020
Market Analysis	Value in US$ Mn
Key Regions Covered	North America Latin America Europe East Asia South Asia Oceania Middle East Africa
Key Countries Covered	U.S. Canada Brazil Mexico Argentina Germany France Italy U.K. Spain BENELUX Russia China Japan South Korea India Thailand Indonesia Malaysia Australia New Zealand GCC Countries Turkey South Africa
Key Market Segments Covered	By Form By Manufacturing Process By Application Region
Key Companies Covered	MilliporeSigma (Merck KGaA) Danher Life Sciences GE Healthcare (General Electric) Fujifilm Healthcare Catalent Lonza- Pharma & biotech CPC (Colder Products Co.) Thermo Fisher Scientific Sartorius Stedim Biotech Asahi Kasei Medical Boehringer Ingelheim Corning Eppendorf Repligen Solesis Medical (Fenner PLC) Dickinson and Company Bio-Rad Laboratories Charles River laboratories.

Bioprocess Technology Industry Research Key Segments

• By Type

  • Cell Culture
  • Cell Expansion
  • Flow Cytometry
  • Cell Line Development
  • Virus Infiltration

• By Application

  • Biopharmaceuticals
  • Specialty Products
  • Industry Chemicals
  • Environment Management Aid

• By End User

  • Hospitals
  • Research labs
  • Medical Institutions
  • Others